 |
|
UCSF finds potential new antibody treatment for autoimmune diseases
January 23, 2009Scientists at UCSF have discovered an abnormality in a patient's immune system that may lead to safer therapies for autoimmune diseases such as rheumatoid arthritis and colitis, as well as potential new ways to treat transplant rejection.
The research identified antibodies from a woman's immune system that prevent infection-fighting T cells from moving through her blood stream and entering her body's organs to attack invaders such as bacteria or viruses. Findings appear in the current online edition of "The FASEB Journal," the official journal of the Federation of American Societies for Experimental Biology.
Based on studies in which the woman's antibodies were transferred into mice, researchers hope these antibodies can be used to treat patients with autoimmunity or transplant recipients whose immune systems attack a transplanted organ or tissue.
Autoimmunity occurs when the body perceives its own cells or tissue as foreign organisms and creates an immune response to itself. Autoimmune diseases affect approximately five to eight percent of Americans and their prevalence is increasing, according to the National Institute of Allergy and Infectious Diseases. The majority of people with autoimmune diseases are women.
"This is the first selective antibody of its type discovered in a patient," said lead study author Edward J. Goetzl, MD, UCSF professor of medicine and immunology. "Antibodies that react more generally against blood cells, such as T cells, previously have been identified. However, this is the first to block a specific aspect of T-cell function. Our study offers a potential new approach to developing safer, more targeted therapies based on human antibodies."
Therapies using proper doses of these newly discovered antibodies may carry less risk of infections or tumors than current treatments, since the antibodies target T cells' specific patrolling activities, rather than their overall function.
Goetzl's team evaluated a woman with a low number of blood T cells and frequent infections in the ears, urinary tract and lungs. The infection of several organs suggested a defect in the patient's immune system similar to Acquired Immune Deficiency Syndrome (AIDS), but the patient tested negative for human immunodeficiency virus (HIV).
Further studies revealed that the patient's CD4 T cells did not move out of her lymph nodes as they would in a normal immune system because her body created antibodies to one type of sphingosine 1-phosphate (S1P) receptor. S1P is critical to appropriate immune responses since it regulates T- and B-cell movement throughout the body by interacting with its receptor. The patient's antibodies blocked the signaling that triggers T-cell movement from the thymus and lymph nodes into blood and then into many organs.
Researchers then explored whether the woman's antibodies effectively could inhibit an autoimmune response in mice. Antibodies against the S1P receptor, created from the patient's antibody-producing cells, were injected into mice that were induced to develop colitis. The result was a significant reduction in severity of their diseases, including colitis-associated weight loss, in those mice compared to mice that did not receive the antibodies.
"These results have broad biological implications, since the cells that carry out our immune responses are present in every organ," said Goetzl, director of UCSF Allergy and Immunology Research, which focuses on developing new diagnostic approaches and treatments for allergic and immunological diseases.
Funds from UCSF, the National Institutes of Health and the Rainin Post-Doctoral Training Fund, an independent foundation, supported this research.
Co-authors of the study are Jia-Jun Liao, Mei-Chuan Huang, Katharine Fast, Katherine Gundling, and Mahesh Yadav, all from the UCSF Department of Medicine; Matthias R. Wabl of the UCSF Department of Microbiology-Immunology; and James R. Van Brocklyn of the Ohio State University Department of Pathology.
UCSF is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. For further information, visit http://www.ucsf.edu
The University of California, San Francisco
Autoimmunity occurs when the body perceives its own cells or tissue as foreign organisms and creates an immune response to itself. Autoimmune diseases affect approximately five to eight percent of Americans and their prevalence is increasing, according to the National Institute of Allergy and Infectious Diseases. The majority of people with autoimmune diseases are women.
"This is the first selective antibody of its type discovered in a patient," said lead study author Edward J. Goetzl, MD, UCSF professor of medicine and immunology. "Antibodies that react more generally against blood cells, such as T cells, previously have been identified. However, this is the first to block a specific aspect of T-cell function. Our study offers a potential new approach to developing safer, more targeted therapies based on human antibodies."
Therapies using proper doses of these newly discovered antibodies may carry less risk of infections or tumors than current treatments, since the antibodies target T cells' specific patrolling activities, rather than their overall function.
Goetzl's team evaluated a woman with a low number of blood T cells and frequent infections in the ears, urinary tract and lungs. The infection of several organs suggested a defect in the patient's immune system similar to Acquired Immune Deficiency Syndrome (AIDS), but the patient tested negative for human immunodeficiency virus (HIV).
Further studies revealed that the patient's CD4 T cells did not move out of her lymph nodes as they would in a normal immune system because her body created antibodies to one type of sphingosine 1-phosphate (S1P) receptor. S1P is critical to appropriate immune responses since it regulates T- and B-cell movement throughout the body by interacting with its receptor. The patient's antibodies blocked the signaling that triggers T-cell movement from the thymus and lymph nodes into blood and then into many organs.
Researchers then explored whether the woman's antibodies effectively could inhibit an autoimmune response in mice. Antibodies against the S1P receptor, created from the patient's antibody-producing cells, were injected into mice that were induced to develop colitis. The result was a significant reduction in severity of their diseases, including colitis-associated weight loss, in those mice compared to mice that did not receive the antibodies.
"These results have broad biological implications, since the cells that carry out our immune responses are present in every organ," said Goetzl, director of UCSF Allergy and Immunology Research, which focuses on developing new diagnostic approaches and treatments for allergic and immunological diseases.
Funds from UCSF, the National Institutes of Health and the Rainin Post-Doctoral Training Fund, an independent foundation, supported this research.
Co-authors of the study are Jia-Jun Liao, Mei-Chuan Huang, Katharine Fast, Katherine Gundling, and Mahesh Yadav, all from the UCSF Department of Medicine; Matthias R. Wabl of the UCSF Department of Microbiology-Immunology; and James R. Van Brocklyn of the Ohio State University Department of Pathology.
UCSF is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. For further information, visit http://www.ucsf.edu
The University of California, San Francisco
Autoimmune Diseases Current Events and Autoimmune Diseases News RSSNational report shines light on lupus 50-year treatment drought
Today, The Lewin Group, a national health care consulting firm, issued recommendations on ways to overcome the barriers that have obstructed lupus drug development resulting in no new drug approval for this disease in more than 50 years - since the Eisenhower Administration.
Visionary concept earns La Jolla Institute scientist prestigious NIH Pioneer Award
A scientist at the La Jolla Institute for Allergy & Immunology has received one of the National Institutes of Health (NIH)'s top awards -- the 2009 NIH Director's Pioneer Award.
Master gene that switches on disease-fighting cells identified by scientists
The master gene that causes blood stem cells to turn into disease-fighting 'Natural Killer' (NK) immune cells has been identified by scientists, in a study published in Nature Immunology today.
Endothelin-Related Drugs Benefit Patients With Pulmonary Hypertension
Recent research to block the effects of endothelin, a powerful substance that constricts blood vessels and stimulates cell growth, has led to successful treatment of pulmonary arterial hypertension and provides hope for treating other chronic diseases.
Promising new target emerges for autoimmune diseases
University of Michigan scientists say they have uncovered a fundamentally new mechanism that holds in check aggressive immune cells that can attack the body's own cells.
Blood pressure medication to treat multiple sclerosis?
Conventional blood pressure medication can treat inflammation in an animal model mimicking multiple sclerosis (MS). This discovery was made by Dr. Michael Platten, head consultant at the department of Neurooncology at Heidelberg University Hospital and head of the Helmholtz Experimental Neuroimmunology Junior Research Group on at the German Cancer Research Center and his team in cooperation with scientists from Stanford University in California.
Taking the Needle's Sting Out of Diabetes
Found in 30% of all human cancer tumors, the Ras protein literally "drives cells crazy," says Prof. Yoel Kloog, the dean of the Faculty of Life Sciences at Tel Aviv University. Prof. Kloog was the first in the world to develop an effective anti-Ras drug against pancreatic cancer, currently in clinical trials.
Sun exposure may trigger certain autoimmune diseases in women
Ultraviolet (UV) radiation from sunlight may be associated with the development of certain autoimmune diseases, particularly in women.
The right messenger for a healthy immune response
Researchers from the Molecular Immunology group at the Helmholtz Centre for Infection Research (HZI) in Braunschweig, Germany have now shown that Beta-Interferon also plays a crucial role during an immune response: without Beta-Interferon immune cells are unable to show "wanted posters" of pathogens to other cells.
Gene regulates immune cells' ability to harm the body
A recently identified gene allows immune cells to start the self-destructive processes thought to underlie autoimmune diseases such as multiple sclerosis (MS) and rheumatoid arthritis.
More Autoimmune Diseases Current Events and Autoimmune Diseases News Articles
 |
Living Well with Autoimmune Disease: What Your Doctor Doesn't Tell You...That You Need to Know by Mary J. Shomon (Author) Are you tired? Achy? Depressed? Overweight? You could be suffering from an autoimmune disease. Autoimmune disease is the third major category of illness in the United States, yet very little is known about the many serious and chronic immune conditions. If you're one of the 50 million Americans suffering from one kind of autoimmune disease-whether it's lupus, rheumatoid arthritis, multiple sclerosis, thyroid disease, fibromyalgia, chronic fatigue syndrome, or Crohn's disease-there's a good chance you'll develop another. This book can help. Written by Mary J. Shomon, a well-known patient advocate who was diagnosed with autoimmune disease in 1995, this guide to alternative and natural remedies shows you how to treat the underlying causes of immune system... |
 |
Anti-Aging Vibes Rhodiola Rosea Nutrition Supplement, 60 Capsules by Anti-Aging Vibes For centuries, the herb Rhodiola has been used in traditional medicine in Russia, Scandinavia, and other countries, and is a perfect candidate for supplementing the Anti-Aging Vibes Core Program. Rhodiola is a powerful "adaptogenic" herb, meaning that it has a broad range of actions with no known downsides In fact, Mongolian doctors used it to support healthy lung and cell function.* Further research shows that it protects from mental and physical stress, toxins, and cold temperature stress.* Rhodiola Rosea contains active ingredients that are responsible for its wide range of beneficial actions. Anti-Aging Vibes Rhodiola is "standardized" to contain at least 3 percent rosavin, the primary active compound in the herb. Rosavin doesn't account for all of the herb's activity and our... |
 |
The Autoimmune Epidemic by Donna Jackson Nakazawa (Author), Dr. Douglas Kerr (Foreword) From the foreword by Dr. Douglas Kerr, Director, Johns Hopkins Transverse Myelitis Center "The Autoimmune Epidemic by Donna Jackson Nakazawa is an astounding book....It is the kind of book that will rivet you and scare you. It will make you angry. It will amaze you with the courage of some of the people described in the book...The Autoimmune Epidemic is every bit as compelling as Upton Sinclair's The Jungle...It is also every bit as necessary as An Inconvenient Truth.... You will leave this book with no reservations about the veracity of the conclusions: put simply, there is no doubt that autoimmune diseases are on the rise and increasing environmental exposures of toxins and chemicals is fueling this rise. The research is sound. The conclusions unassailable.... Reading The... |
 |
Wampole ELISA II Test Kits, Scl-70 II - Autoimmune Disease Kits - Model 437470CE by Inverness Medical These enzyme-linked immunosorbent assay (ELISA) test kits are capable of being run in a manual, semi-automated, or fully automated capacity with customized instrumentation packages available to suit individual laboratory needs. Kits come in breakaway, removable test wells in a microplate format, with color-coded, ready-to-use reagents. Assays use interchangeable substrate, stop solution, and wash buffer. This uniformity of reagents allows for ease of automation with microtiter processing systems. Kits provide flexible testing with simple procedures, a broad menu, and accurate results. The autoimmune disease kits offer a wide range of ELISA tests, including an antinuclear antibody (ANA) screen, specific reflex tests, and extractable nuclear antibody (ENA) kits. Enteric disease kits... |
 |
Unlocking the Mystery of Wheat and Gluten Intolerance Also With: Dr. Thomas O'Bryan (Host), Sueson Vess (Host) This 2-plus hour DVD of the June 17,2006 seminar at College of DuPage, Glen Ellyn, IL is a valuable learning tool for those interested in gluten intolerance and the connection to autoimmune diseases. Learn how to implement and follow a gluten-free diet for improved health and wellness. In sensitive individuals, gluten intolerance triggers Auto-Immune Diseases, Attention Deficient Disorders, Epilepsy, Multiple Sclerosis, Migraines, Chronic Fatigue Syndrome, and more. During this seminar, learn how all may be related to gluten intolerance. |
 |
What Your Doctor May Not Tell You About Autoimmune Disorders: The Revolutionary, Drug-Free Treatments for Thyroid Disease, Lupus, MS, IBD, Chronic Fatigue; Rheumatoid Arthritis, and Other Diseases by Stephen B. Edelson (Author), Deborah Mitchell (Author) Autoimmune disorders are not well understood and therefore difficult to treat. The result is that there are millions of Americans who are suffering because they aren't being diagnosed properly, or getting the correct medical treatment they need. Here, Dr. Edelson discusses the most common types of autoimmune diseases, including lupus, Chron's disease, thyroid disease, rheumatoid arthritis, and chronic fatigue syndrome, outlining their symptoms, causes, and risk factors. He describes his own revolutionary program for treating the root of all autoimmune disorders-without drugs-providing readers with new hope for getting back on the road to better health. |
 |
Camu Camu Powder Extract (Myrciaria dubia) - 100 mg - 60 capsules by www.GlobalFusion.us South Garden Products are manufactured under the highest standards and rigorous processes such as GMP (Good Manufacturing Practices), HACCP, JAS (Japanese Agricultural Standards) and the NOP (National Organic Program). Certifications were issued by SGS Group and Skal International in compliance with adequate production, processing and commercialization principles. South Garden Organic products exhibit the USDA Organic seal. |
|
Immunol Focus Autoimmune Video 5 [VHS] Starring: Johnstone | |
 |
Body Wars (non-profit) Starring: Adam Harrington Directed By: Glenn Krawczyk Also With: Glenn Krawczyk (Writer), Stephen H. Schwartz (Producer), Andrew Waterworth (Producer), Michael Stedman (Producer) |
 |
Gastric Gold Aloe Vera AMP 90 Count Bottle by Alternative Health Products Gastric Gold is helpful in reversing and correcting many digestive and gastrointestinal tract disorders and diseases. A.M.P. (Aloe Mucilaginous Polysaccharide) the main ingredient in Gastric Gold purifies the blood, cleanses the liver, restores and protects the digestive tract, while it works to stop the damaging causes of these painful conditions: The Aloe Vera plant has been recognized for many years for its remarkable health-enhancing properties. In the past it was known for external applications for the skin only. Concentrated and stabilized Aloe (AMP) the active ingredient in Gastric Gold, is now widely used to help a variety of conditions in the digestive tract. The digestive tract is designed to ensure nutrients from food are absorbed into the blood stream while dispensing with... |
| © 2009 BrightSurf.com |